Australian Dollar (AUD)

Proceeds to fund Phase 1/2 trial of EO2463 OncoMimics™, as a monotherapy or in combination, to treat multiple forms of...

Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network

Press release June 12th, 2025 Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils...

CREDIT AGRICOLE SA: Crédit Agricole Santé & Territoires announces the signing of an agreement to acquire Petits-fils, the leading provider of at-home services for seniors in France, from Clariane

Press Release Montrouge, 12 June 2025 Crédit Agricole Santé & Territoires announces the signing of an agreement to acquire Petits-fils,...

Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect treatment comparison

Cross-study findings indicate significant clinical benefit of frontline fixed-duration ibrutinib plus venetoclax with improved likelihood of undetectable minimal residual disease...

Novartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNH

In the Phase IIIB APPULSE-PNH study, adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who switched to Fabhalta experienced clinically meaningful...

Operational Update